Oncology Institute Inc (TOI) Stock Forecast & Price Target
Oncology Institute Inc · NASDAQ
$5.20+0.22 (+4.42%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Oncology Institute Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $7.00 to $10.00, a moderate spread. The average target of $8.50 sits 63% above the current $5.20. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.04 next quarter toward $-0.03 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Oncology Institute Inc.
As of Jul, 4 of 4 firms rate TOI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TOI EPS & revenue forecast
EPS · NEXT QUARTER
$-0.04
Range $-0.06 – $0.00 · 5 analysts · -74% YoY
Next period, 5 analysts expect Oncology Institute Inc to earn $-0.04 a share (range $-0.06 – $0.00), versus $-0.14 a year earlier. Full-year consensus is $-0.14, growing to $-0.03 the year after.
REVENUE · NEXT QUARTER
$171.2M
Range $166.2M – $177.8M · 5 analysts · +25% YoY
Revenue is expected to reach $171.2M (range $166.2M – $177.8M), +25.3% year-over-year. Full-year consensus is $655.5M, rising to $825.5M next year.
Top analysts covering Oncology Institute Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TOI.
#1
David Larsen
BTIG
Buy
$9.00+73.1% to target
Coverage
—
+ Follow
#2
MS
Matthew Shea
Needham
Buy
$7.00+34.6% to target
Coverage
—
+ Follow
#3
BH
Ben Haynor
Lake Street
Buy
$10.00+92.3% to target
Coverage
—
+ Follow
#4
YZ
Yuan Zhi
B. Riley Securities
Buy
$8.00+53.8% to target
Coverage
—
+ Follow
TOI stock forecast FAQ
What is TOI's average 12-month price target?+
The 4 analysts with a live target average $8.50 for Oncology Institute Inc over the next 12 months, ranging from a $10.00 high to a $7.00 low.
Is TOI stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TOI?+
The Street-high target is $10.00 (Lake Street), and the Street-low is $7.00 (Needham). The average of all 4 active targets is $8.50.
How many Wall Street analysts cover TOI?+
4 analysts have an active rating on Oncology Institute Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering TOI?+
Among analysts who currently cover TOI, David Larsen of BTIG has the strongest overall Quantellect track record. Their current call is Buy with a $9.00 target.
What is Oncology Institute Inc's projected EPS for next quarter?+
The consensus estimate is $-0.04 per share (range $-0.06 – $0.00) across 5 analysts. Full-year EPS is projected at $-0.14, rising to $-0.03 the following year.
How much revenue is Oncology Institute Inc expected to report next quarter?+
Consensus revenue is $171.2M (range $166.2M – $177.8M). Full-year revenue is projected at $655.5M, growing to $825.5M next year.
Have analysts been upgrading or downgrading TOI lately?+
As of Jul, 4 of 4 firms rate TOI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TOI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
